CHARLES SCHWAB INVESTMENT MANAGEMENT INC - TRANSLATE BIO INC ownership

TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 49 filers reported holding TRANSLATE BIO INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of TRANSLATE BIO INC
ValueSharesWeighting
Q2 2021$14,454,000
+59.9%
524,805
-4.2%
0.01%
+66.7%
Q1 2021$9,038,000
-6.3%
548,084
+4.8%
0.00%
-25.0%
Q4 2020$9,644,000
+56.0%
523,230
+15.2%
0.00%
+33.3%
Q3 2020$6,184,000
+169.1%
454,318
+254.3%
0.00%
+200.0%
Q2 2020$2,298,000
+151.7%
128,234
+40.1%
0.00%0.0%
Q1 2020$913,000
+30.1%
91,501
+6.2%
0.00%
Q4 2019$702,000
-4.7%
86,176
+15.9%
0.00%
Q3 2019$737,000
-21.5%
74,3300.0%0.00%
-100.0%
Q2 2019$939,000
+40.8%
74,330
+13.6%
0.00%
Q1 2019$667,000
+376.4%
65,438
+252.0%
0.00%
Q4 2018$140,000
-24.7%
18,5900.0%0.00%
Q3 2018$186,00018,5900.00%
Other shareholders
TRANSLATE BIO INC shareholders Q3 2018
NameSharesValueWeighting ↓
Omega Fund Management, LLC 2,437,601$24,376,00011.53%
DAFNA Capital Management LLC 151,739$1,517,0000.62%
Bain Capital Public Equity Management, LLC 738,543$7,385,0000.52%
Baupost Group 6,491,287$62,393,0000.48%
Rock Springs Capital Management LP 1,009,179$10,092,0000.36%
SPHERA FUNDS MANAGEMENT LTD. 276,639$2,766,0000.32%
Cormorant Asset Management, LP 454,550$4,546,0000.30%
Artal Group S.A. 600,000$6,000,0000.16%
Perceptive Advisors 500,000$5,000,0000.13%
ArrowMark Colorado Holdings LLC 367,744$3,677,0000.03%
View complete list of TRANSLATE BIO INC shareholders